SynthesisFrontiers in medicine2026
National-, institutional-, and individual-level determinants of dermatologic research excellence: an analysis of Stanford-Elsevier Lists of the top 2% scholars worldwide (2017-2023).
Synthesis in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Skin diseases contribute to a massive and often overlooked component of the global disease burden, highlighting the need for a better understanding of the dermatologic research landscape and its key drivers of excellence. Aim: To explore the national, institutional, and individual-level determinants that shape dermatologic research excellence worldwide. Methods: We analyzed the publicly available Stanford-Elsevier Lists of the top 2% most-cited scientists (2017-2023), extracting scholars classified in Results: EDS were overwhelmingly based in high-income countries (97.9% Conclusion: Dermatologic research excellence remains concentrated in high-income, predominantly European and Anglophone ecosystems, within a small cadre of elite institutions and among older, male scholars. Policymakers should focus on targeted funding for under-represented regions and institutional reforms to ensure equitable career advancement for women in academic dermatology.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.